Daewoong Pharma Cash Flow-to-Debt Ratio
Daewoong Pharma cash flow-to-debt ratio. Daewoong Pharma (069620) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2025, meaning its operating cash flow of ₩57.53 Billion could theoretically repay 0% of its total liabilities (₩1.26 Trillion) in one year. Check Daewoong Pharma investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Daewoong Pharma (2007–2024)
Cash flow-to-debt ratio of Daewoong Pharma from 2007 to 2024. Historical debt coverage capacity for Daewoong Pharma across 16 annual periods. Check Daewoong Pharma (069620) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Daewoong Pharma Cash Flow-to-Debt Ratio by Year (2007–2024)
Daewoong Pharma cash flow-to-debt ratio by year from 2007 to 2024. Year-by-year debt coverage analysis for Daewoong Pharma. For the full cash flow conversion analysis, see Daewoong Pharma cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.05x | ₩51.49 Billion | ₩1.05 Trillion | ▼ -71.8% |
| 2023 | 0.17x | ₩132.57 Billion | ₩762.77 Billion | ▲ +20.9% |
| 2022 | 0.14x | ₩118.21 Billion | ₩822.12 Billion | ▲ +156.3% |
| 2021 | 0.06x | ₩39.99 Billion | ₩712.77 Billion | ▼ -62.7% |
| 2020 | 0.15x | ₩100.98 Billion | ₩671.66 Billion | ▲ +59.2% |
| 2019 | 0.09x | ₩57.60 Billion | ₩609.75 Billion | ▲ +19.3% |
| 2018 | 0.08x | ₩47.50 Billion | ₩600.04 Billion | ▼ -55.7% |
| 2017 | 0.18x | ₩103.94 Billion | ₩581.99 Billion | ▲ +527.3% |
| 2016 | 0.03x | ₩15.38 Billion | ₩540.15 Billion | ▼ -71.1% |
| 2015 | 0.10x | ₩35.89 Billion | ₩364.29 Billion | ▼ -9.3% |
| 2014 | 0.11x | ₩25.95 Billion | ₩238.76 Billion | ▼ -71.7% |
| 2013 | 0.38x | ₩54.16 Billion | ₩141.05 Billion | ▼ -18.3% |
| 2012 | 0.47x | ₩45.02 Billion | ₩95.76 Billion | ▼ -18.8% |
| 2011 | 0.58x | ₩78.82 Billion | ₩136.04 Billion | ▲ +283.6% |
| 2008 | 0.15x | ₩31.33 Billion | ₩207.39 Billion | ▼ -27.9% |
| 2007 | 0.21x | ₩25.81 Billion | ₩123.24 Billion | — |